NRAS and melanoma: It is infrequently mutated in acquired melanocytic nevi (<5%) but is the predominant mutated driver oncogene in congenital nevi; 95% of large congenital nevi are NRAS mutant, and these lesions have a higher propensity for melanoma transformation [13,14,48,49].